FDA approves long acting facial filler
The FDA has approved the use of Sculptra Aesthetic long acting facial filler that builds collagen. Sculptra Aesthetic (injectable poly-L-lactic acid) has been approved for use by a trained physician to correct shallow to deep nasolabial fold (smile lines) contour deficiencies and other facial wrinkles. The injectable dermal filler works gradually to offer natural-looking results that can last up to two years. The treatment was available in Europe for a decade.
-
Anti-wrinkle product SculptraAesthetic approved
FDA approval for EVOLENCE
FDA-approved wrinkle treatment hits US market
Biocompatibles Filing For CE Mark Approval For Dermal Filler Bead
FDA approves VeraFil implants for permanent lip augmentation
